.ANALYSIS FEATURE.06 August 2024.
A large randomized measured test along with cisgender girls highlights the challenges of fidelity to an everyday oral preexposure prevention regiment and also shows that twice-yearly treatment of lenacapavir can maintain effective HIV prevention degrees over 6 months.